• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Bellevue Life Sciences Acquisition Corp.

    11/14/24 4:47:55 PM ET
    $BLAC
    Blank Checks
    Finance
    Get the next $BLAC alert in real time by email
    SC 13G 1 fp0091017-5_sc13g.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (AMENDMENT NO. 0)*

     

    Bellevue Life Sciences Acquisition Corp.

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    079174108

    (CUSIP Number)

     

    Marcus Collins

    RiverNorth Capital Management, LLC

    360 S. Rosemary Avenue, Ste. 1420

    West Palm Beach, Florida 33401

    561-484-7185

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    September 30, 2024

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [x] Rule 13d-1(b)

    [  ] Rule 13d-1(c)

    [  ] Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 079174108   13G   Page 2 of 5 Pages

     

    1.

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    RIVERNORTH CAPITAL MANAGEMENT, LLC

     
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [  ]

    (b) [  ]

    3.

    SEC USE ONLY

     

     
    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

    DELAWARE

     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5.

    SOLE VOTING POWER

     

    245,115

    6.

    SHARED VOTING POWER

     

    None

    7.

    SOLE DISPOSITIVE POWER

     

    245,115

    8.

    SHARED DISPOSITIVE POWER

     

    None

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    245,115

     
    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [  ]

     

     
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.07%

     
    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IA

     


     

     

    CUSIP No. 079174108   13G   Page 3 of 5 Pages

     

    Item 1. (a)

    Name of Issuer

    Bellevue Life Sciences Acquisition Corp.

         
      (b)

    Address of Issuer’s Principal Executive Offices

    10900 NE 4th Street, Suite 2300

    Bellevue, Washington 98004

     

    Item 2. (a)

    Name of Person Filing

    RiverNorth Capital Management, LLC

         
      (b)

    Address of the Principal Office or, if none, residence

    360 S. Rosemary Avenue, Ste. 1420

    West Palm Beach, Florida 33401

         
      (c)

    Citizenship

    Delaware

         
      (d)

    Title of Class of Securities

    Common Stock, par value $0.0001 per share

         
      (e)

    CUSIP Number

    079174108

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) [  ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) [  ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) [  ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) [  ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) [x] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) [  ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) [  ] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) [  ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) [  ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) [  ] Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

     

    CUSIP No. 079174108   13G   Page 4 of 5 Pages

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned: 245,115
    (b) Percent of class: 6.07%
    (c) Number of shares as to which the person has:  
      (i) Sole power to vote or to direct the vote: 245,115
      (ii) Shared power to vote or to direct the vote: None
      (iii) Sole power to dispose or to direct the disposition of: 245,115
      (iv) Shared power to dispose or to direct the disposition of: None

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

    Instruction. Dissolution of a group requires a response to this item.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Other persons have the right to receive the proceeds from the sale of the securities reported herein.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

     

    CUSIP No. 079174108   13G   Page 5 of 5 Pages

     

    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      RiverNorth Capital Management, LLC  
           
      By: /s/ Marcus Collins  
      Name: Marcus Collins  
      Title: General Counsel and Chief Compliance Officer  
           
      Date: November 14, 2024  

     

     

     

     

     

    Get the next $BLAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

      OSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025Under the symbol "OSRH" SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination"). The Company now operates as "OSR Holdings, Inc." following the successful completion of the Business Combination.  Beginning on Tuesday, February 18, 2025, the common stock and warrants of the Company

      2/14/25 6:10:00 PM ET
      $BLAC
      Blank Checks
      Finance
    • Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.

      SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders (the "Special Meeting") held today, including the proposal for the business combination with OSR Holdings Co., Ltd. (the "Transaction").  BLAC expects the Transaction to close following receipt of foreign investment approval from the Industrial Bank of Korea, which is expected on February 14, 2025.  Following the Special Meeting, BLAC filed its Amended and Restated Certific

      2/13/25 4:10:00 PM ET
      $BLAC
      Blank Checks
      Finance
    • Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting

      BELLEVUE, Wash., May 13, 2024 /PRNewswire/ -- As previously announced, on May 10, 2024, Bellevue Life Sciences Acquisitions Corp. (NASDAQ:BLAC) ("BLAC") convened a special meeting of stockholders (the "Special Meeting"), adjourned the Special Meeting without any business being conducted, and announced that the Special Meeting will be reconvened at 9:00 a.m. Pacific time on Tuesday, May 14, 2024, at 925 Fourth Avenue, Suite 2900, Seattle, WA 98104. At the reconvened Special Meeting, stockholders will consider and vote upon the matters described in BLAC's definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on April 26, 2024 (the "Proxy Statement"). BL

      5/13/24 9:05:00 AM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Kim Sang Harry

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:09 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Cho Joong Myung

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:12 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Barberis Alcide

      3 - OSR Holdings, Inc. (0001840425) (Issuer)

      2/21/25 4:15:10 PM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      11/14/24 4:47:55 PM ET
      $BLAC
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      8/14/24 8:00:58 AM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Bellevue Life Sciences Acquisition Corp.

      SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      2/8/24 4:20:10 PM ET
      $BLAC
      Blank Checks
      Finance

    $BLAC
    SEC Filings

    See more
    • Bellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Leadership Update, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits

      8-K - OSR Holdings, Inc. (0001840425) (Filer)

      2/21/25 4:10:12 PM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 25-NSE filed by Bellevue Life Sciences Acquisition Corp.

      25-NSE - OSR Holdings, Inc. (0001840425) (Subject)

      2/18/25 8:16:26 AM ET
      $BLAC
      Blank Checks
      Finance
    • SEC Form 425 filed by Bellevue Life Sciences Acquisition Corp.

      425 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)

      2/13/25 4:14:40 PM ET
      $BLAC
      Blank Checks
      Finance